Hypera SA is a pharmaceutical company, which engages in the manufacture and distribution of medical and cosmetics products. The company is headquartered in Sao Paulo, Sao Paulo. The company went IPO on 2008-04-16. The firm operates in several markets with a variety of pharmaceutical products. The firm's products include: Mantecorp Farmasa, which is an under the umbrella brand; Addera D3, Nesina, Dramin, Alivium, Predsim, Lisador, and Rinosoro, which focus on several medical specialties involving primary care which are present in main therapeutic classes; Mantecorp Skincare, which offer dermo cosmetics recommended by dermatologists and also operates in this segment with the brands Simple Organic, which offers organic, vegan, and cruelty-free products, and Bioage, which focuses on the professional aesthetic treatment market; and Apracur, Benegrip, Buscopan, Coristina D Pro, Engov, Epocler, Estomazil, and Neosaldina, which are over-the-counter medications provided throughout Brazil.
최신 재무제표(Form-10K)에 따르면, Hypera S.A.의 총 자산은 $0이며, 순손실입니다.
HYPMY의 주요 재무 비율은 무엇인가요?
Hypera S.A.의 유동비율은 0이고, 순이익률은 0, 주당 매출은 $0입니다.
Hypera S.A.의 매출은 부문 또는 지역별로 어떻게 나뉘나요?
Hypera S.A. 주요 수익원은 Medicines, Cosmetics, Perfumery and Personal Care Products이며, 최신 수익 발표에서 수익은 7,442,466,000입니다. 지역별로는 Brazil이 Hypera S.A.의 주요 시장이며, 수익은 7,442,466,000입니다.